Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Christopher R Cunningham"'
Autor:
Alexander Daoud, Jessica A. Kozel, Jacqueline R. Batanian, Christopher R Cunningham, Jordan B. Slutsky, Reena Varade
Publikováno v:
Journal of Cutaneous Pathology. 48:285-289
Dermatofibrosarcoma protuberans (DFSP) is a rare sarcoma of the skin arising from the dermis. Its location is most commonly presented on the trunk of middle-aged adults and rarely on the face. The characteristic genetic aberration in the form of a re
Publikováno v:
Radiology Case Reports, Vol 15, Iss 5, Pp 637-640 (2020)
Radiology Case Reports
Radiology Case Reports
We report a case of a collision tumor, a meningioma complicated with metastasis from a primary renal cell carcinoma. A 75-year-old man, with known history of renal cell carcinoma, and 10-year history of stable meningioma developed neurological sympto
Publikováno v:
Annals of diagnostic pathology. 55
Background Immunotherapy is increasingly used for treatment of metastatic melanoma and carcinomas. PD-1 (programmed death 1) and its associated ligand (PD-L1) inhibits the activation of T-lymphocytes. This inhibition can be impacted by a number of dr
Publikováno v:
J Endourol Case Rep
Background: Renal cell carcinoma (RCC) recurrence can present in nearly any location. Rarely, recurrence is within the venous system. Previous reports of such recurrent tumor thrombectomy have all used an open approach. For the first time, we present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340034b3e0f49cbc98b7411578d67882
https://europepmc.org/articles/PMC7803276/
https://europepmc.org/articles/PMC7803276/
Publikováno v:
American Journal of Clinical Pathology. 154:S48-S49
Introduction/Objective Immunotherapy is increasingly used for the treatment of metastatic melanoma and carcinomas. PD-I (programmed death 1) and its associated ligand (PD-L1) inhibits the activation of T lymphocytes. This inhibition can be impacted b
Autor:
Shaela A. Avery, Christopher R. Cunningham, David W. Macdonald, Ryan S. Squires, Jason Adams, Nicholas B. Heimann, Melissa Baker, Robert E. Seegmiller, David L. Kooyman
Publikováno v:
International Journal of Molecular Sciences; Volume 14; Issue 8; Pages: 16515-16531
International Journal of Molecular Sciences, Vol 14, Iss 8, Pp 16515-16531 (2013)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 14, Iss 8, Pp 16515-16531 (2013)
International Journal of Molecular Sciences
Heterozgyous spondyloepiphyseal dysplasia congenita (sedc/+) mice expressing a missense mutation in col2a1 exhibit a normal skeletal morphology but early-onset osteoarthritis (OA). We have recently examined knee articular cartilage obtained from homo
Autor:
Irene, Litvan, Peter S J, Lees, Christopher R, Cunningham, Shesh N, Rai, Alexander C, Cambon, David G, Standaert, Connie, Marras, Jorge, Juncos, David, Riley, Stephen, Reich, Deborah, Hall, Benzi, Kluger, Yvette, Bordelon, David R, Shprecher
The cause of progressive supranuclear palsy (PSP) is largely unknown. Based on evidence for impaired mitochondrial activity in PSP, we hypothesized that the disease may be related to exposure to environmental toxins, some of which are mitochondrial i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f6e5a4a254ee566ccfa83050199aee14
https://europepmc.org/articles/PMC4861658/
https://europepmc.org/articles/PMC4861658/
Autor:
David M, Brody, Irene, Litvan, Steve, Warner, David E, Riley, Deborah A, Hall, Benzi M, Kluger, David R, Shprecher, Christopher R, Cunningham
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 31(5)
The pathophysiology of both PD and PSP is characterized by a pro-oxidant state. Uric acid is an oxidative stress marker. High uric acid blood levels have been associated with a reduced risk of PD and a decreased rate of disease progression. We invest
Autor:
Christine D. Berg, Thomas L. Riley, Martin C. Tammemägi, Kathryn L. Taylor, Christopher R. Cunningham
Publikováno v:
JNCI: Journal of the National Cancer Institute. 106
The US National Lung Screening Trial (NLST) demonstrated that annual low-dose computed tomography (LDCT) lung cancer screening reduces lung cancer mortality by 20% compared with chest x-ray (CXR) screening (1). Consequently, several organizations, as
Autor:
Jerome Mabie, E. David Crawford, Thomas Riley, Philip C. Prorok, Christopher R. Cunningham, Lawrence R. Ragard, Christine D. Berg, Gerald L. Andriole, Robert L. Grubb, Amanda Black, Paul F. Pinsky
Publikováno v:
Journal of Urology. 187